The relationship between alcohol consumption and chronic kidney disease in patients with nonalcoholic fatty liver disease

References

• Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases. Hepatology. 2018;67(1):328–357. doi:10.1002/hep.29367.
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73–84. doi:10.1002/hep.28431.
   PubMed Web of Science ®Google Scholar
• Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62(1 Suppl):S47–S64. doi:10.1016/j.jhep.2014.12.012.
   PubMed Web of Science ®Google Scholar
• Cai X, Sun L, Liu X, et al. Non-alcoholic fatty liver disease is associated with increased risk of chronic kidney disease. Ther Adv Chronic Dis. 2021;12:20406223211024361. doi:10.1177/20406223211024361.
   Web of Science ®Google Scholar
• Marcuccilli M, Chonchol M. NAFLD and chronic kidney disease. Int J Mol Sci. 2016;17(4):562. doi:10.3390/ijms17040562.
   PubMed Web of Science ®Google Scholar
• Önnerhag K, Dreja K, Nilsson PM, et al. Increased mortality in non-alcoholic fatty liver disease with chronic kidney disease is explained by metabolic comorbidities. Clin Res Hepatol Gastroenterol. 2019;43(5):542–550. doi:10.1016/j.clinre.2019.02.004.
   PubMed Web of Science ®Google Scholar
• Tao Z, Li Y, Cheng B, et al. Influence of nonalcoholic fatty liver disease on the occurrence and severity of chronic kidney disease. J Clin Transl Hepatol. 2022;10(1):164–173. doi:10.14218/JCTH.2021.00171.
   PubMed Web of Science ®Google Scholar
• de Boer IH, Caramori ML, Chan JC, et al. KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 2020;98(4):S1–S115. doi:10.1016/j.kint.2020.06.019.
   PubMed Web of Science ®Google Scholar
• Jespersen T, Kruse N, Mehta T, et al. Light wine consumption is associated with a lower odd for cardiovascular disease in chronic kidney disease. Nutr Metab Cardiovasc Dis. 2018;28(11):1133–1139. doi:10.1016/j.numecd.2018.06.018.
   PubMed Web of Science ®Google Scholar
• Umesawa M, Sairenchi T, Haruyama Y, et al. Validity of a risk prediction equation for CKD after 10 years of follow-up in a japanese population: the Ibaraki prefectural health study. Am J Kidney Dis. 2018;71(6):842–850. doi:10.1053/j.ajkd.2017.09.013.
   PubMed Web of Science ®Google Scholar
• Tomiyama C, Higa A, Dalboni MA, et al. The impact of traditional and non-traditional risk factors on coronary calcification in pre-dialysis patients. Nephrol Dial Transplant. 2006;21(9):2464–2471. doi:10.1093/ndt/gfl291.
   PubMed Web of Science ®Google Scholar
• Kwon I, Jun DW, Moon J-H. Effects of moderate alcohol drinking in patients with nonalcoholic fatty liver disease. Gut Liver. 2019;13(3):308–314. doi:10.5009/gnl18175.
   PubMed Web of Science ®Google Scholar
• Hajifathalian K, Torabi Sagvand B, McCullough AJ. Effect of alcohol consumption on survival in nonalcoholic fatty liver disease: a national prospective cohort study. Hepatology. 2019;70(2):511–521. doi:10.1002/hep.30226.
   PubMed Web of Science ®Google Scholar
• Lai Y-J, Chen Y-Y, Lin Y-K, et al. Alcohol consumption and risk of chronic kidney disease: a nationwide observational cohort study. Nutrients. 2019;11(9):2121. doi:10.3390/nu11092121.
   PubMed Web of Science ®Google Scholar
• Hu EA, Lazo M, Rosenberg SD, et al. Alcohol consumption and incident kidney disease: results from the atherosclerosis risk in communities study. J Ren Nutr. 2020;30(1):22–30. doi:10.1053/j.jrn.2019.01.011.
   PubMed Web of Science ®Google Scholar
• Dunkler D, Kohl M, Teo KK, et al. Population-attributable fractions of modifiable lifestyle factors for CKD and mortality in individuals with type 2 diabetes: a cohort study. Am J Kidney Dis. 2016;68(1):29–40. doi:10.1053/j.ajkd.2015.12.019.
   PubMed Web of Science ®Google Scholar
• Roerecke M, Rehm J. Alcohol consumption, drinking patterns, and ischemic heart disease: a narrative review of meta-analyses and a systematic review and meta-analysis of the impact of heavy drinking occasions on risk for moderate drinkers. BMC Med. 2014;12(1):182. doi:10.1186/s12916-014-0182-6.
   PubMedGoogle Scholar
• Hashimoto Y, Imaizumi T, Kato S, et al. Effect of body mass index on the association between alcohol consumption and the development of chronic kidney disease. Sci Rep. 2021;11(1):20440. doi:10.1038/s41598-021-99222-y.
   PubMed Web of Science ®Google Scholar
• Yuan H, Yu Q, Bai H, et al. Alcohol intake and the risk of chronic kidney disease: results from a systematic review and dose–response meta-analysis. Eur J Clin Nutr. 2021;75(11):1555–1567. doi:10.1038/s41430-021-00873-x.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhu B, Song N, et al. Alcohol consumption and its association with chronic kidney disease: evidence from a 12-year China health and nutrition survey. Nutr Metab Cardiovasc Dis. 2022;32(6):1392–1401. doi:10.1016/j.numecd.2022.02.012.
   PubMed Web of Science ®Google Scholar
• Paulson QX, Hong J, Holcomb VB, et al. Effects of body weight and alcohol consumption on insulin sensitivity [J]. Nutr J. 2010;9(1):14. (doi:10.1186/1475-2891-9-14.
   PubMedGoogle Scholar
• Fernández-Solà J. Cardiovascular risks and benefits of moderate and heavy alcohol consumption. Nat Rev Cardiol. 2015;12(10):576–587. doi:10.1038/nrcardio.2015.91.
   PubMed Web of Science ®Google Scholar
• Lee J-H, Kim D, Kim HJ, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 2010;42(7):503–508. doi:10.1016/j.dld.2009.08.002.
   PubMedGoogle Scholar
• Meffert PJ, Baumeister SE, Lerch MM, et al. Development, external validation, and comparative assessment of a new diagnostic score for hepatic steatosis. Am J Gastroenterol. 2014;109(9):1404–1414. doi:10.1038/ajg.2014.155.
   PubMed Web of Science ®Google Scholar
• Inker LA, Astor BC, Fox CH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63(5):713–735. doi:10.1053/j.ajkd.2014.01.416.
   PubMed Web of Science ®Google Scholar
• Shah AG, Lydecker A, Murray K, et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009;7(10):1104–1112. doi:10.1016/j.cgh.2009.05.033.
   PubMed Web of Science ®Google Scholar
• McCullough K, Sharma P, Ali T, et al. Measuring the population burden of chronic kidney disease: a systematic literature review of the estimated prevalence of impaired kidney function. Nephrol Dial Transplant. 2012;27(5):1812–1821. doi:10.1093/ndt/gfr547.
   PubMed Web of Science ®Google Scholar
• Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol. 2013;10(11):686–690. doi:10.1038/nrgastro.2013.171.
   PubMed Web of Science ®Google Scholar
• Cao Y, Deng Y, Wang J, et al. The association between NAFLD and risk of chronic kidney disease: a cross-sectional study. Ther Adv Chronic Dis. 2021;12:20406223211048649. doi:10.1177/20406223211048649.
   Web of Science ®Google Scholar
• Byrne CD, Targher G. NAFLD as a driver of chronic kidney disease. J Hepatol. 2020;72(4):785–801. doi:10.1016/j.jhep.2020.01.013.
   PubMed Web of Science ®Google Scholar
• Francque SM, Van Der Graaff D, Kwanten WJ. Non-alcoholic fatty liver disease and cardiovascular risk: pathophysiological ­mechanisms and implications. J Hepatol. 2016;65(2):425–443. doi:10.1016/j.jhep.2016.04.005.
   PubMed Web of Science ®Google Scholar
• Lee Y-J, Cho S, Kim SR. Effect of alcohol consumption on kidney function: population-based cohort study. Sci Rep. 2021;11(1):2381. doi:10.1038/s41598-021-81777-5.
   PubMed Web of Science ®Google Scholar
• Cheungpasitporn W, Thongprayoon C, Kittanamongkolchai W, et al. High alcohol consumption and the risk of renal damage: a systematic review and meta-analysis. QJM: an Int J Med. 2015;108(7):539–548. doi:10.1093/qjmed/hcu247.
   PubMed Web of Science ®Google Scholar
• Gaziano JM, Buring JE, Breslow JL, et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med. 1993;329(25):1829–1834. doi:10.1056/NEJM199312163292501.
   PubMed Web of Science ®Google Scholar
• Wakasugi M, Kazama JJ, Yamamoto S, et al. A combination of healthy lifestyle factors is associated with a decreased incidence of chronic kidney disease: a population-based cohort study. Hypertens Res. 2013;36(4):328–333. doi:10.1038/hr.2012.186.
   PubMed Web of Science ®Google Scholar
• Muntner P, Coresh J, Smith JC, et al. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int. 2000;58(1):293–301. doi:10.1046/j.1523-1755.2000.00165.x.
   PubMed Web of Science ®Google Scholar
• Mukamal KJ, Jadhav PP, D’Agostino RB, et al. Alcohol consumption and hemostatic factors: analysis of the framingham offspring cohort. Circulation. 2001;104(12):1367–1373. doi:10.1161/hc3701.096067.
   PubMed Web of Science ®Google Scholar
• Drel VR, Sybirna N. Protective effects of polyphenolics in red wine on diabetes associated oxidative/nitrative stress in streptozotocin-diabetic rats. Cell Biol Int. 2010;34(12):1147–1153. doi:10.1042/CBI20100201.
   PubMed Web of Science ®Google Scholar
• Nakamura T, Fujiwara N, Sugaya T, et al. Effect of red wine on urinary protein, 8-hydroxydeoxyguanosine, and liver-type fatty acid–binding protein excretion in patients with diabetic nephropathy. Metabolism. 2009;58(8):1185–1190. doi:10.1016/j.metabol.2009.03.019.
   PubMed Web of Science ®Google Scholar
• Yahfoufi N, Alsadi N, Jambi M, et al. The immunomodulatory and anti-inflammatory role of polyphenols. Nutrients. 2018;10(11):1618. doi:10.3390/nu10111618.
   PubMed Web of Science ®Google Scholar
• Davies MJ, Baer DJ, Judd JT, et al. Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial. Jama. 2002;287(19):2559–2562. doi:10.1001/jama.287.19.2559.
   PubMed Web of Science ®Google Scholar
• Joosten M, Beulens J, Kersten S, et al. Moderate alcohol consumption increases insulin sensitivity and ADIPOQ expression in postmenopausal women: a randomised, crossover trial. Diabetologia. 2008;51(8):1375–1381. doi:10.1007/s00125-008-1031-y.
   PubMed Web of Science ®Google Scholar
• Chen J, Muntner P, Hamm LL, et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol. 2003;14(2):469–477. doi:10.1097/01.asn.0000046029.53933.09.
   PubMed Web of Science ®Google Scholar
• Kubo M, Kiyohara Y, Kato I, et al. Effect of hyperinsulinemia on renal function in a general Japanese population: the hisayama study. Kidney Int. 1999;55(6):2450–2456. doi:10.1046/j.1523-1755.1999.00458.x.
   PubMed Web of Science ®Google Scholar
• Estruch R, Sacanella E, Badia E, et al. Different effects of red wine and gin consumption on inflammatory biomarkers of atherosclerosis: a prospective randomized crossover trial: effects of wine on inflammatory markers. Atherosclerosis. 2004;175(1):117–123. doi:10.1016/j.atherosclerosis.2004.03.006.
   PubMed Web of Science ®Google Scholar
• Burchfiel CM, Tracy RE, Chyou P-H, et al. Cardiovascular risk factors and hyalinization of renal arterioles at autopsy: the honolulu heart program. Arterioscler Thromb Vasc Biol. 1997;17(4):760–768. doi:10.1161/01.atv.17.4.760.
   PubMed Web of Science ®Google Scholar
• Scott R, Reddy K, Husain K, et al. Dose response of ethanol on antioxidant defense system of liver, lung, and kidney in rat. Pathophysiology. 2000;7(1):25–32. doi:10.1016/s0928-4680(99)00034-6.
   PubMedGoogle Scholar
• Femia R, Natali A, L’Abbate A, et al. Coronary atherosclerosis and alcohol consumption: angiographic and mortality data. Arterioscler Thromb Vasc Biol. 2006;26(7):1607–1612. doi:10.1161/01.ATV.0000222929.99098.1f.
   PubMed Web of Science ®Google Scholar
• Ojeda NB, Hennington BS, Williamson DT, et al. Oxidative stress contributes to sex differences in blood pressure in adult growth-restricted offspring. Hypertension. 2012;60(1):114–122. doi:10.1161/HYPERTENSIONAHA.112.192955.
   PubMed Web of Science ®Google Scholar
• Wang X, Desai K, Juurlink B, et al. Gender-related differences in advanced glycation endproducts, oxidative stress markers and nitric oxide synthases in rats. Kidney Int. 2006;69(2):281–287. doi:10.1038/sj.ki.5000043.
   PubMed Web of Science ®Google Scholar
• Chen WY, Rosner B, Hankinson SE, et al. Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. Jama. 2011;306(17):1884–1890. doi:10.1001/jama.2011.1590.
   PubMed Web of Science ®Google Scholar
• Liangpunsakul S, Chalasani N. What do we recommend our patients with NAFLD about alcohol use?. Am J Gastroenterol. 2012;107(7):976–978. doi:10.1038/ajg.2012.20.
   PubMed Web of Science ®Google Scholar
• Knox J, Scodes J, Witkiewitz K, et al. Reduction in World Health Organization risk drinking levels and cardiovascular disease. Alcohol Clin Exp Res. 2020;44(8):1625–1635. doi: 10.1111/acer.14386.
   Google Scholar